In neurology, Lusofarmaco presents an innovative molecule belonging to triptans' class; by virtue of some unique features, this drug is proposed as a reliable treatment for the control of migraines, particularly effective with relapsing episodes. In this area, Lusofarmaco's commitment is synonymous of continuity in tradition. Since 1956 – with the launch of one of the first drugs used for the treatment of schizophrenia, and subsequently of another molecule that is still today a reference drug for the antipsychotic class of medications, thus confirming at the beginning of the new millennium its undiscussed leadership in this sector of pharmaceutical industry – the list of products has gradually increased in number due to the inclusion of numerous molecules that not only guarantee coverage of many therapeutic areas, but also represent a true turning point in the pharmacological approach to the treatment of neuropsychiatric disorders.

Brand Active Ingredient ATC Pack Reimbuersement Status
AURADOL Frovatriptan Triptan 2 tablets 2,5 mg Class: A
6 tablets 2,5 mg Class: A
ITALEPT Levetiracetam Antiepileptic 60 tablets 500 mg Class: A
30 tablets 1.000 mg Class: A
 300 ml Oral Solution 100mg/ml Class: A
OLLAT Lacosamide Antiepileptic 56 Coated Tablets 50mg  Class: A
56 Coated Tablets 100mg  Class: A
56 Coated Tablets 150mg Class: A
56 Coated Tablets 200mg Class: A
PRELYNCA Pregabalin Neurological Analgesics Caps - 25 mg 14 CPS Class: A04
Caps - 75 mg 56 CPS Class: A04
Caps - 150 mg 56 CPS Class: A04
ROLDAP Rasagiline Antiparkinson 28 Tablets 1 mg Class: A*
SERENASE Aloperidol Antipsychotics 20 tablets 1 mg Class: C
drops 2 mg/ml 0,2% 15 ml Class: C
20 tablets 5 mg Class: A
drops 10 mg/ml 1% 15 ml Class: A

*Prescription subject to diagnosis and therapeutic plan drawn up by neurological centers

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.


Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl


Copyright 2024 Istituto Lusofarmaco D'Italia S.p.A.